Pharmaceutical Company to Produce Affordable Insulin in Petersburg

AmerisourceBergen Kicks Off Strategic Relationship with Civica

AmerisourceBergen will serve as Civica, Inc.’s exclusive distribution partner, providing supply chain support for Civica’s products and working to ensure that Civica’s crucial products reach its members across the country efficiently, reliably and securely. The partnership aims to accelerate mutual efforts to ensure the stability of supply of essential generic medicines nationwide.

Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative

“As a renowned injection device specialist with over 35 years’ experience, Ypsomed will help Civica make self-administered care more affordable for Americans living with diabetes,” said Ned McCoy, President and Chief Executive Officer of Civica. “Civica will deliver affordable, high-quality insulin, in the best pen platform, utilizing our new, state of the art manufacturing technology in Petersburg, Virginia.”

Utah-based Nonprofit Set to Open $140M Insulin Plant in Petersburg

Petersburg is at the center of a nonprofit’s push to lower sky-high insulin costs. Utah-based Civica Rx is in the final stages of building a $140 million insulin production plant in the city.

California Selects Civica Rx as Its Insulin Manufacturing Partner

California’s partnership with Civica is a game changer,” said California Governor Gavin Newsom, announcing the state’s choice of Civica to manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative. “We are proud to be working with Civica to bring true price competition into the insulin drug market and ease the financial burden for Californians living with diabetes.”

CivicaScript, SortPak Partner to Package & Deliver Medicines to Maximize Patient Convenience, Compliance & Savings

CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and SortPak, which delivers pre-sorted medications to patients at no extra cost to patients or health plans, are partnering to provide CivicaScript medicines in packaging designed to maximize patient convenience, savings and medication compliance.

What Spurred Lilly, Novo and Sanofi to Slash Insulin Prices? Expert Gives Her Take

The price cuts can be explained by a mix of factors, Leemore Dafny, Ph.D., wrote in a new analysis for The New England Journal of Medicine, titled “Falling Insulin Prices – What Just Happened?” One: The market is awaiting the entry of certain manufacturers that “don’t benefit from high prices.” Two: Government regulations are making it “costlier” for insulin manufacturers to keep charging their prior prices. Three: Public shaming.

CivicaRx Disrupts Out of Control Prescription Medication Pricing

Civica believes its model of rallying others to work together to ensure a reliable supply of fairly priced medicines is one that the wider pharmaceutical industry can ultimately support.

Hard Hats & Hello’s

Celebrating the power of innovation and collaboration with our new neighbors in Petersburg, Virginia, and hearing from the Davis family about the road they travel with Type 1 Diabetes.

Jay Benson Joins Civica Rx as Chief Manufacturing and Supply Chain Officer

Biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer, replacing Russ Gall who recently announced his retirement.

Civica Celebrates 5th Anniversary

Today, we celebrate Civica’s 5th Anniversary! Five years of building our talented team and lasting partnerships with likeminded organizations. Five years of delivering on and expanding our mission to make quality generic medications available and affordable to everyone. And, five years of doing what is in the best interest of patients.

We thank the Civica team for all they do to put patients first; our members and partners for their dedication to our shared mission; and the generous donors who are helping to make affordable insulin a reality. We are deeply appreciative and look forward to continuing our work together. Our mission is as important as ever!
Watch this video to see how far we’ve come and what’s next!

Bouwien Smits Joins Civica Rx as Site Vice President and General Manager of New Virginia Manufacturing Facility

Industry veteran Bouwien Smits will run state-of-the-art production of low-cost insulin as well as dozens of other medicines.

Civica Rx Named a Best Place to Work

Civica has been named a Best Place to Work by BioSpace, recognized in part for its emphasis on culture and innovation.

Podcast: Tackling Drug Shortages, High Prices

Civica President and CEO Ned McCoy drills down into Civica’s business model, talks about the rationale for building a U.S.-based manufacturing plant and explores what drugs might be next on Civica’s radar.